1 |
Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults [J]. Am J Med, 2004, 116(1): 14-18.
|
2 |
Durand E, Mousseaux E, Coste P, et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up [J]. Eur Heart J, 2008, 29(3): 348-355.
|
3 |
中华医学会心血管病学分会中国成人肥厚型梗阻性心肌病诊断与治疗指南编写组. 2017中国成人肥厚型心肌病诊断与治疗指南 [J]. 中华心血管病杂志, 2017, 45(12): 1015-1032
|
4 |
Alashi A, Smedira NG, Hodges K, et al. Outcomes in guideline-based class i indication versus earlier referral for surgical myectomy in hypertrophic obstructive cardiomyopathy [J]. J Am Heart Assoc, 2021,10(1): e016210.
|
5 |
Ji Q, Wang YL, Yang Y, et al. Mini-invasive surgical instruments in transaortic myectomy for hypertrophic obstructive cardiomyopathy: a single-center experience with 168 cases [J]. J Cardiothorac Surg, 2021,16(1): 25.
|
6 |
Bytyçi I, Nistri S, Mörner S, et al. Alcohol septal ablation versus septal myectomy treatment of obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis [J]. J Clin Med, 2020, 9(10): 3062.
|
7 |
Batzner A, Pfeiffer B, Neugebauer A, et al. Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy [J]. J Am Coll Cardiol, 2018, 72(24): 3087-3094.
|
8 |
Oto A, Aytemir K, Okutucu S, et al. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy [J]. J Interv Cardiol, 2011,24(1): 77-84.
|
9 |
Guerrero I, Dhoble A, Fasulo M, et al. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy [J]. Catheter Cardiovasc Interv, 2016, 88(6): 971-977.
|
10 |
Liu F, Fu J, Hsi D, et al. Percutaneous intramyocardial septal radiofrequency ablation for interventricular septal reduction: an ovine model with 1-year outcomes [J]. Cardiology, 2020, 145(1): 53-62.
|
11 |
Liu L, Li J, Zuo L, et al. Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy [J]. J Am Coll Cardiol, 2018, 72(16): 1898-1909.
|
12 |
Cooper RM, Shahzad A, Hasleton J, et al. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation [J]. Europace, 2016,18(1): 113-120.
|
13 |
Creta A, Elliott P, Earley MJ, et al. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study [J]. Europace, 2021, 23(9): 1409-1417.
|